Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Quipt Home Medical's Debt-to-EBITDA or its related term are showing as below:
QIPT'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.63 Med: 2.08 Max: 3.35
Current: 2.27
During the past 13 years, the highest Debt-to-EBITDA Ratio of Quipt Home Medical was 3.35. The lowest was -1.63. And the median was 2.08.
QIPT's Debt-to-EBITDA is not ranked
in the Medical Distribution industry.
Industry Median: 2.29
vs QIPT: 2.27
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Quipt Home Medical Debt-to-EBITDA Related Terms
Quipt Home Medical Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Quipt Home Medical's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Quipt Home Medical's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quipt Home Medical Debt-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Quipt Home Medical's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Quipt Home Medical's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Dec. 2025) EBITDA data.
Quipt Home Medical (QIPT) has a Debt-to-EBITDA of 1.85 as of Dec. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Quipt Home Medical. This is 11% below median its historical median of 2.08.
Is Quipt Home Medical's Debt-to-EBITDA too high?
Quipt Home Medical's current Debt-to-EBITDA of 1.85 is 11% below median its 10-year median of 2.08. The Medical Distribution industry median Debt-to-EBITDA is 2.29. Quipt Home Medical's value of 1.85 is 19.2% below this industry median. Overall, Quipt Home Medical has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Quipt Home Medical's Debt-to-EBITDA compare to ACH and EDAP?
Quipt Home Medical's Debt-to-EBITDA of 1.85 can be compared against companies in the Medical Distribution industry. The industry median Debt-to-EBITDA is 2.29. Quipt Home Medical's value of 1.85 is 19.2% below this benchmark. While the company's 10-year median is 2.08 vs. the industry median of 2.29, Quipt Home Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Distribution company?
The median Debt-to-EBITDA among Medical Distribution companies is 2.29, based on 91 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quipt Home Medical's current Debt-to-EBITDA of 1.85 is 19.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Quipt Home Medical. For the Medical Distribution industry, the median Debt-to-EBITDA is 2.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quipt Home Medical's current Debt-to-EBITDA is 1.85, which is 11% below median its own 10-year median of 2.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quipt Home Medical stock overvalued right now?
Quipt Home Medical (QIPT) has a current Debt-to-EBITDA of 1.85. The stock's GF Value™ is $3.77, compared to a current price of $3.65 — trading 3.2% below its estimated fair value. The current Debt-to-EBITDA is 1.85, which is 11% below median its 10-year median of 2.08 and 19.2% below the Medical Distribution industry median of 2.29. Quipt Home Medical's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Quipt Home Medical (QIPT), the current Debt-to-EBITDA is 1.85 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Quipt Home Medical (QIPT) Overvalued in 2026?
Based on GuruFocus' analysis, Quipt Home Medical stock appears to be undervalued.
The current stock price of $3.65 is trading 3.2% below its estimated GF Value™ of $3.77.
Key valuation signals for QIPT:
Debt-to-EBITDA: 1.85 (11% below median its 10-year median of 2.08)
GF Value™: $3.77 vs. price of $3.65 (3.2% below fair value)
Industry Position: 19.2% below the Medical Distribution median
No single metric tells the full story. See the QIPT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quipt Home Medical Corp is a provider of durable medical equipment (DME) and home medical equipment (HME) in the United States. The Company specializes in delivering in-home treatments for the management of chronic conditions, with a primary focus on respiratory diseases, and supports patients with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. Its products and services include Sleep Apnea and PAP treatment, home medical equipment, home ventilation, and custom mobility solutions. The Company operates in a single business segment, comprising the sale and rental of medical equipment and related devices, and serves patients across 27 states in the United States.
62GF Score
Get the complete analysis for QIPT
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
QIPT has been successfully added to your 
